Amphetamine Cocaine Interaction Study - 2
Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Terminated
CT.gov ID
NCT00000305
Collaborator
National Institute on Drug Abuse (NIDA) (NIH), University of Texas (Other)
0
1
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 1 |
Study Design
Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Amphetamine Cocaine Interaction Study
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Please contact site for information.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Texas Health Science Center | Houston | Texas | United States | 77225 |
Sponsors and Collaborators
- The University of Texas Health Science Center, Houston
- National Institute on Drug Abuse (NIDA)
- University of Texas
Investigators
- Principal Investigator: John Grabowski, Ph.D., University of Texas
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00000305
Other Study ID Numbers:
- NIDA-09262-2
- P50DA009262
- P50-09262-2
First Posted:
Sep 21, 1999
Last Update Posted:
May 18, 2012
Last Verified:
May 1, 2012